Xin Lang Cai Jing·2026-03-17 11:27Core Viewpoint - Shareholders Gu Xiaolei and Gu Meifang of Zhaoyan New Drug have revised their share reduction plan from a maximum of 30.7425 million shares, accounting for 4.1026% of the total share capital, to a maximum of 3.00% of the company's total share capital within three months after the announcement [1] Summary by Category Share Reduction Plan - Gu Xiaolei plans to reduce holdings through centralized bidding of up to 5.0206 million shares and block trading of up to 10.0412 million shares, totaling no more than 15.0618 million shares, which represents 2.01% of the total share capital [1] - Gu Meifang intends to reduce holdings through centralized bidding of up to 2.4728 million shares and block trading of up to 4.9456 million shares, totaling no more than 7.4184 million shares, which accounts for 0.99% of the total share capital [1] - The reduction period is set from March 20, 2026, to June 19, 2026 [1]